GlassScriptPhysician profile
Hannah L Hartranft
NPI 1689290215
$5,456.10
in general payments reported to CMS, 2019-2025
37 companies · $865 in 2025
The $865 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $427 · 2022: $1,244 · 2023: $1,464 · 2024: $1,456 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,784.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $689.50 | 2021-2025 | |
| Glaxosmithkline, LLC. | $676.61 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $656.43 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $579.77 | 2022-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $365.15 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $339.41 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $209.26 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.80 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Biohaven Pharmaceutical Holding Company LTD. | $177.43 | 2022 | |
| Exact Sciences Corporation | $129.49 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $110.81 | 2022-2025 | Rexulti |
| Amgen INC. | $98.07 | 2021-2025 | Repatha, Otezla |
| Axsome Therapeutics, INC. | $91.89 | 2022-2024 | Auvelity |
| Astellas Pharma US INC | $87.78 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $80.08 | 2022-2024 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Hartranft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.